The FDA on Friday approved aficamten (Myqorzo) for symptomatic obstructive hypertrophic cardiomyopathy (HCM), drugmaker ...

SaveHealth reports on popular statin medications that lower cholesterol and cardiovascular risks, highlighting their benefits ...

The clearance is the first in Cytokinetics’ lengthy history and pits its drug Myqorzo against Bristol Myers’ Camzyos, which ...

Cytokinetics Inc. won US approval for a drug to treat a deadly heart condition, posing a potential threat to sales of a ...

Dementia prevention is a critical area of research, as experts want to understand what people can do to decrease dementia risk. A recent study found that more than 5 years of taking medications like ...

Real-world data show semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) are linked with lower risk of major ...

Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to a new study. Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to ...

For years, people taking one of the world’s most common heart drugs have described the same nagging side effect: sore, aching ...

Identifying the commonalities between cardiovascular disease and cancer could lead to improved treatments for both. Sveta Zi/iStock via Getty Images Plus What would you guess are the two biggest ...

Statins are already among the top-selling prescription drugs in the U.S. for the treatment of heart disease. Now, a new study suggests that the popular cholesterol-lowering drugs have a significant ...

Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to a new study from Karolinska Institutet published in Alzheimer's & Dementia: The Journal of the Alzheimer's ...